Eléments de l'association

	Mark S. Carey	3
	Antineoplastic Combined Chemotherapy Protocols (adverse effects)	13
	Mark S. Carey *Sauf* Antineoplastic Combined Chemotherapy Protocols (adverse effects)"	2
	Antineoplastic Combined Chemotherapy Protocols (adverse effects) *Sauf* Mark S. Carey"	12
	Mark S. Carey Et Antineoplastic Combined Chemotherapy Protocols (adverse effects)	1
	Mark S. Carey Ou Antineoplastic Combined Chemotherapy Protocols (adverse effects)	15
	*Corpus*	3114

List of bibliographic references

Number of relevant bibliographic references: 1.

Ident.	Authors (with country if any)	Title
000837	Amit M. Oza [Canada] ; Adrian D. Cook [Royaume-Uni] ; Jacobus Pfisterer [Allemagne] ; Andrew Embleton [Royaume-Uni] ; Jonathan A. Ledermann [Royaume-Uni] ; Eric Pujade-Lauraine [France] ; Gunnar Kristensen [Norvège] ; Mark S. Carey [Canada] ; Philip Beale [Australie] ; Andrés Cervantes [Espagne] ; Tjoung-Won Park-Simon [Allemagne] ; Gordon Rustin [Royaume-Uni] ; Florence Joly [France] ; Mansoor R. Mirza [Danemark] ; Marie Plante [Canada] ; Michael Quinn [Australie] ; Andrés Poveda [Espagne] ; Gordon C. Jayson [Royaume-Uni] ; Dan Stark [Royaume-Uni] ; Ann Marie Swart [Royaume-Uni] ; Laura Farrelly [Royaume-Uni] ; Richard Kaplan [Royaume-Uni] ; Mahesh K B. Parmar [Royaume-Uni] ; Timothy J. Perren [Royaume-Uni]	Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024